| Literature DB >> 29160836 |
Fozia Shaheen1, Muhammad Hammad Aziz2, Muhammad Fakhar-E-Alam3,4, Muhammad Atif5,6, Mahvish Fatima7, Riaz Ahmad8, Atif Hanif9, Saqib Anwar10, Fatima Zafar11, Ghazanfar Abbas12, Syed Mansoor Ali13, Mukhtar Ahmed14.
Abstract
Graphene-based materials have garnered significant attention because of their versatile bioapplications and extraordinary properties. Graphene oxide (GO) is an extremely oxidized form of graphene accompanied by the functional groups of oxygen on its surface. GO is an outstanding platform on which to pacify silver nanoparticles (Ag NPs), which gives rise to the graphene oxide-silver nanoparticle (GO-Ag) nanocomposite. In this experimental study, the toxicity of graphene oxide-silver (GO-Ag) nanocomposites was assessed in an in vitro human breast cancer model to optimize the parameters of photodynamic therapy. GO-Ag was prepared using the hydrothermal method, and characterization was done by X-ray diffraction, field-emission scanning electron microscope (FE-SEM), transmission Electron Microscopy (TEM), energy dispersive X-rays Analysis (EDAX), atomic force microscopy and ultraviolet-visible spectroscopy. The experiments were done both with laser exposure, as well as in darkness, to examine the phototoxicity and cytotoxicity of the nanocomposites. The cytotoxicity of the GO-Ag was confirmed via a methyl-thiazole-tetrazolium (MTT) assay and intracellular reactive oxygen species production analysis. The phototoxic effect explored the dose-dependent decrease in the cell viability, as well as provoked cell death via apoptosis. An enormously significant escalation of ¹O₂ in the samples when exposed to daylight was perceived. Statistical analysis was performed on the experimental results to confirm the worth and clarity of the results, with p-values < 0.05 selected as significant. These outcomes suggest that GO-Ag nanocomposites could serve as potential candidates for targeted breast cancer therapy.Entities:
Keywords: biocompatibility; cytotoxicity; graphene oxide (GO); photodynamic therapy; reactive oxygen species (ROS)
Year: 2017 PMID: 29160836 PMCID: PMC5707618 DOI: 10.3390/nano7110401
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1X-Ray diffraction (XRD) structure of (a) Graphene Oxide (GO) (b) Graphene Oxide-silver (GO-Ag) nanocomposites.
Figure 2Scanning Electron Microscopy (SEM) analysis of (a) GO (b) GO-Ag nanocomposites (c) Energy Dispersive X-rays (EDAX) analysis of GO-Ag nanocomposites (d) Transmission electron microscopy (TEM) of GO-Ag.
Figure 3Atomic Force Microscopy (AFM) analysis of GO-Ag nanocomposites.
Figure 4UV–visible of (a) GO and GO-Ag nanocomposites (b) Ag NPs.
Figure 5Absorbance versus concentration of GO-Ag nanocomposites.
Figure 6(a) Loss in cellular viability (%) in MCF-7 breast cell line treated with GO-Ag nanocomposites after 24 h, t-test (* p < 0.05) (b) Linear calibration Plot of GO-Ag vs. cell viability.
Figure 7Morphological changes of breast cells when treated with GO-Ag. (a) control; (b) 20 µg/mL; (c) 40 µg/mL; (d) 80 µg/mL; (e) 100 µg/mL.
Figure 8Qualitative characterization of reactive oxygen species (ROS) formation by H2DCFDA staining using fluorescence microscopy (a) Control MCF-7 cell line; (b) MCF-7 cells treated with GO; (c) MCF-7 cells treated with Ag NPs; and (d) MCF-7 cells treated with GO-Ag nanocomposite.
Figure 9ROS Fluorescence in MCF-7 cells Model after Labeling with Ag NPs and GO-Ag (microgram/mL).
Figure 10Quantum yield of singlet oxygen of GO-Ag, silver nanoparticles (Ag NPs), GO in comparison to MB.
Figure 11(a) Cellular viability of GO-Ag treated breast cell carcinoma using PDT (100 J/cm2), t-test (* p < 0.05); (b) Linear calibration Plot of GO-Ag vs. cell viability under PDT (100 J/cm2).
Figure 12(a) ROS generation under light irradiation of suitable wavelength (430 nm), t-test (* p < 0.05); (b) Linear calibration Plot of GO-Ag concentrationvs. ROS fluorescence under PDT (100 J/cm2).
Figure 13Schematic diagram represented the ROS accumulation by GO-Ag under light irradiation of 430 nm.